Ondansetron Injection, Solution
Product Images NDC 0409-2271

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 0409-2271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ondansetron 01)

FDA Label Image

Logo (Ondansetron 02)

FDA Label Image

Principal Display Panel (2 mL Vial Label)

This is a description of an Ondansetron injection, USP in a 2 mL single-dose vial with a concentration of 4 mg/2 mL (2 mg/mL). The product needs to be protected from light and is distributed by Hospira, Inc. It includes a unique product code: PAA242281.*

FDA Label Image

Principal Display Panel (2 mL Vial Carton.)

Each 1 mL of aqueous solution contains 9.0 mg of citric acid anhydrous with 2 mg of ondansetron, 0.46 mg of sodium citrate ondansetron hydrochloride dihydrate, and 0.25 mg of sodium chloride as buffers. This solution features Novaplus Ondansetron Injection, USP, with a concentration of 4 mg/2 mL (2 mg/mL). This sterile solution is available in 2 mL vials.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.